Effective with date of service Sept. 22, 2021, the Medicaid and NC Health Choice programs cover tisotumab vedotin-tftv for use in the PADP when billed with HCPCS code J9999.
Medicaid Bulletin
Articles published prior to January 2018 are available in the Medicaid Bulletin Archive.
NC Medicaid is extending all current COVID-19 temporary provider rate increases through Dec. 31, 2021.
Effective with date of service Aug. 23, 2021, the Medicaid and NC Health Choice programs cover pneumococcal 20-valent conjugate vaccine for use in the PADP when billed with HCPCS code 90677.
Billing guidelines for PADP when billed with HCPCS code J3490.
The National Committee for Quality Assurance (NCQA) has developed a Kidney Health Toolkit to assist in bringing awareness to diabetes.
A provider enrollment fee must be collected from Medicaid and NC Health Choice providers initially enrolling in, or revalidating their enrollment in, Medicare, Medicaid or NC Health Choice, or adding a new Medicare practice location.
The NC Medicaid Behavioral Health and Intellectual/Developmental Disabilities (I/DD) Tailored Plans will now launch on Dec. 1, 2022. The original launch date had been planned for July 1, 2022.
Effective with date of service Jan. 1, 2022 (updated from Sept. 29, 2021), the Medicaid and NC Health Choice programs cover Pfizer-BioNTech COVID-19 Vaccine (12 years of age and older).
Effective Nov. 1, 2021, involuntary disenrollments from the Program of All-inclusive Care for the Elderly will no longer be suspended for any reason.
Pfizer Pediatric COVID-19 vaccine is authorized for use under an Emergency Use Authorization for active immunization to prevent COVID-19.